APA (7th ed.) Citation

Henriksen, D. P., Bodtger, U., Sidenius, K., Maltbaek, N., Pedersen, L., Madsen, H., . . . Chawes, B. L. (2018, January). Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma – a systematic review and meta-analysis. European Clinical Respiratory Journal.

Chicago Style (17th ed.) Citation

Henriksen, Daniel P., et al. "Efficacy, Adverse Events, and Inter-drug Comparison of Mepolizumab and Reslizumab Anti-IL-5 Treatments of Severe Asthma – a Systematic Review and Meta-analysis." European Clinical Respiratory Journal Jan. 2018.

MLA (9th ed.) Citation

Henriksen, Daniel P., et al. "Efficacy, Adverse Events, and Inter-drug Comparison of Mepolizumab and Reslizumab Anti-IL-5 Treatments of Severe Asthma – a Systematic Review and Meta-analysis." European Clinical Respiratory Journal, Jan. 2018.